Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 26 of 1714:
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type IX, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage gated, type VIII, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type VII, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type IV, beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type IV, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type III, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type II, beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type II, alpha 2 DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type I, beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type I, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
progesterone receptor TRIAMCINOLONE ACETONIDE Progesterone 94% .179uM .023uM View
progesterone receptor TRIAMCINOLONE ACETONIDE Progesterone 94% .179uM .023uM View
cholinergic receptor, muscarinic 2 CLOZAPINE Muscarinic M2 94% .476uM .169uM View
adrenergic receptor, alpha 2a THIMEROSAL Adrenergic alpha2A 94% .532uM .2uM View
adrenergic receptor, beta 1 TIMOLOL Adrenergic beta1 94% .002603uM .001503uM View
adrenergic, beta-1-, receptor TIMOLOL Adrenergic beta1 94% .002603uM .001503uM View
calcium channel, voltage-dependent, beta 3 subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, beta 2 subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, alpha 1F subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
protein kinase D1 LAMOTRIGINE Phorbol Ester 2% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, beta 1 subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, gamma subunit 8 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, gamma subunit 7 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, gamma subunit 6 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, gamma subunit 5 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, gamma subunit 4 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, gamma subunit 3 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, gamma subunit 2 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, gamma subunit 1 FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
calcium channel, voltage-dependent, beta 4 subunit FLUOXETINE Calcium Channel Type L, Phenylalkylamine 94% 1.126uM 1.095uM View
cholinergic receptor, muscarinic 4 FLUPHENAZINE Muscarinic M4 94% 3.468uM .484uM View
progesterone receptor FLUOCINONIDE Progesterone 94% .022uM .002904uM View
progesterone receptor FLUOCINONIDE Progesterone 94% .022uM .002904uM View
5-hydroxytryptamine receptor 6 DOXEPIN Serotonin 5-HT6 94% .32uM .149uM View
prostaglandin-endoperoxide synthase 1 TOLMETIN Cyclooxygenase COX-1 94% .041uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) TOLMETIN Cyclooxygenase COX-1 94% .041uM NoneNone View
prostaglandin-endoperoxide synthase 1 MECLOFENAMIC ACID Cyclooxygenase COX-1 94% .203uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) MECLOFENAMIC ACID Cyclooxygenase COX-1 94% .203uM NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
sodium channel associated protein 2 DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type III, beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type I, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type IX, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 U-78517F Calcium Channel Type L, Benzothiazepine 93% 1.65uM 1.466uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CLOTRIMAZOLE Adrenergic, Norepinephrine Transporter 93% 7.936uM 7.87uM View
5-hydroxytryptamine (serotonin) receptor 2B CHLORPROMAZINE Serotonin 5-HT2B 93% .126uM .08uM View
adrenergic receptor, alpha 2b CHLORPROMAZINE Adrenergic alpha2C 93% .374uM .054uM View
adrenergic receptor, alpha 2c (Non-specific probe) CHLORPROMAZINE Adrenergic alpha2C 93% .374uM .054uM View
thromboxane A synthase 1 1-BENZYLIMIDAZOLE Thromboxane Synthetase 93% .602uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) 1-BENZYLIMIDAZOLE Thromboxane Synthetase 93% .602uM NoneNone View
adrenergic receptor, alpha 2a TAMOXIFEN Adrenergic alpha2A 93% 1.935uM .726uM View
chemokine (C-C motif) receptor 2 NIFEDIPINE Chemokine CCR2B 93% 2.191uM .847uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 CISAPRIDE Serotonin Transporter 93% .384uM .204uM View
dopamine receptor D1A CLOMIPRAMINE Dopamine D1 93% 1.113uM .557uM View
dopamine receptor 2 CLOMIPRAMINE Dopamine D2L 93% .413uM .138uM View
5-hydroxytryptamine receptor 6 BENZOTHIAZYL DISULFIDE Serotonin 5-HT6 93% 5.276uM 2.45uM View
A3 adenosine receptor BENZOTHIAZYL DISULFIDE Adenosine A3 93% .347uM .196uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 BENZOTHIAZYL DISULFIDE Dopamine Transporter 93% .245uM .194uM View
5-hydroxytryptamine (serotonin) receptor 2A FLUOXETINE Serotonin 5-HT2A 93% .194uM .055uM View
cholinergic receptor, muscarinic 1 FLUPHENAZINE Muscarinic M1 93% 2.683uM .646uM View
adrenergic receptor, alpha 1d (Non-specific probe) FLUPHENAZINE Adrenergic alpha1D 93% .033uM .016uM View
5-hydroxytryptamine (serotonin) receptor 2C FLUPHENAZINE Serotonin 5-HT2C 93% .067uM .035uM View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CAFFEIC ACID PHENETHYL ESTER Protein Tyrosine Kinase, HER2 Receptor 93% 1.329uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CAFFEIC ACID PHENETHYL ESTER Protein Tyrosine Kinase, HER2 Receptor 93% 1.329uM NoneNone View
adrenergic receptor, beta 2 R-(+)-PROPRANOLOL Adrenergic beta2 93% .076uM .052uM View
mitogen activated protein kinase 1 ISOTRETINOIN Protein Serine/Threonine Kinase, ERK2 93% .462uM NoneNone View
mitogen-activated protein kinase 1 ISOTRETINOIN Protein Serine/Threonine Kinase, ERK2 93% .462uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C MOSAPRIDE Serotonin 5-HT2C 93% .3966uM .2077uM View
adrenergic receptor, alpha 2a BROMOCRIPTINE Imidazoline I2, Central 93% .053uM .035uM View
adrenergic receptor, alpha 2c (Non-specific probe) BROMOCRIPTINE Imidazoline I2, Central 93% .053uM .035uM View
adrenergic receptor, alpha 2a VERAPAMIL Adrenergic alpha2A 93% .579uM .217uM View
adrenergic receptor, alpha 2a LYSERGOL Adrenergic alpha2A 93% .18uM .067uM View
cholinergic receptor, muscarinic 2 MEPAZINE Muscarinic M2 93% .565uM .201uM View
5-hydroxytryptamine (serotonin) receptor 2B MEXILETINE Serotonin 5-HT2B 93% 1.138uM .724uM View
Cytochrom P450-2C19 monooxygenase 1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE CYP450-2C19 Inhibition 93% .2uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 MITOTANE Serotonin Transporter 93% 3.015uM 1.601uM View
prostaglandin-endoperoxide synthase 2 N,N'-DIPHENYL-P-PHENYLENEDIAMINE Cyclooxygenase COX-2 93% .58uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) N,N'-DIPHENYL-P-PHENYLENEDIAMINE Cyclooxygenase COX-2 93% .58uM NoneNone View
cholinergic receptor, muscarinic 4 IRINOTECAN Muscarinic M4 93% 1.556uM .217uM View
Protein-tyrosine kinase, Fyn ITRACONAZOLE Protein Tyrosine Kinase, Fyn 93% 3.89uM NoneNone View
adrenergic receptor, beta 3 PROPRANOLOL Adrenergic beta3 93% .132uM .099uM View
nuclear receptor subfamily 3, group C, member 1 NORETHINDRONE ACETATE Glucocorticoid 93% .646uM .293uM View
adrenergic receptor, alpha 2b OLANZAPINE Adrenergic alpha2C 93% .531uM .077uM View
adrenergic receptor, alpha 2c (Non-specific probe) OLANZAPINE Adrenergic alpha2C 93% .531uM .077uM View
histamine receptor H 1 OLANZAPINE Histamine H1, Central 93% .013uM .001473uM View
5-hydroxytryptamine (serotonin) receptor 2B ONDANSETRON Serotonin 5-HT2B 93% .717uM .456uM View
tachykinin receptor 2 EBASTINE Tachykinin NK2 93% 1.9329uM .6443uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) SULFAPHENAZOLE CYP450-2C9 Inhibition 93% .2uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 SULFAPHENAZOLE CYP450-2C9 Inhibition 93% .2uM NoneNone View
prostaglandin-endoperoxide synthase 1 RESVERATROL Cyclooxygenase COX-1 93% .625uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) RESVERATROL Cyclooxygenase COX-1 93% .625uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CETYLPYRIDINIUM BROMIDE Protein Tyrosine Kinase, HER2 Receptor 93% 1.878uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CETYLPYRIDINIUM BROMIDE Protein Tyrosine Kinase, HER2 Receptor 93% 1.878uM NoneNone View
phosphodiesterase 4A, cAMP specific CANDESARTAN Phosphodiesterase PDE4 93% .2761uM NoneNone View
phosphodiesterase 4C, cAMP-specific CANDESARTAN Phosphodiesterase PDE4 93% .2761uM NoneNone View
phosphodiesterase 4D CANDESARTAN Phosphodiesterase PDE4 93% .2761uM NoneNone View
phosphodiesterase 4B, cAMP specific CANDESARTAN Phosphodiesterase PDE4 93% .2761uM NoneNone View
mitogen activated protein kinase 14 NOVARTIS P-38 INHIBITOR Protein Serine/Threonine Kinase, p38alpha 93% .1868uM NoneNone View
mitogen-activated protein kinase 14 NOVARTIS P-38 INHIBITOR Protein Serine/Threonine Kinase, p38alpha 93% .1868uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B METOCLOPRAMIDE Serotonin 5-HT2B 93% .63uM .401uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ECONAZOLE Adrenergic, Norepinephrine Transporter 93% 2.435uM 2.415uM View
acetylcholinesterase (YT blood group) ECONAZOLE Acetylcholinesterase 93% 13.677uM NoneNone View
adrenergic receptor, alpha 1b CITALOPRAM Adrenergic alpha1B 74% 3.288uM 1.82uM View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase ECONAZOLE Acetylcholinesterase 93% 13.677uM NoneNone View
acetylcholinesterase ECONAZOLE Acetylcholinesterase 93% 13.677uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) MICONAZOLE CYP450-2C9 Inhibition 93% .2uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 MICONAZOLE CYP450-2C9 Inhibition 93% .2uM NoneNone View
dopamine receptor D3 DIETHYLSTILBESTROL Dopamine D3 93% 8.796uM 2.987uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ETHINYLESTRADIOL Adrenergic, Norepinephrine Transporter 93% .959uM .951uM View
mitogen activated protein kinase 1 LIPOPOLYSACCHARIDE E. COLI O55:B5 Protein Serine/Threonine Kinase, ERK2 93% .3208uM NoneNone View
mitogen-activated protein kinase 1 LIPOPOLYSACCHARIDE E. COLI O55:B5 Protein Serine/Threonine Kinase, ERK2 93% .3208uM NoneNone View
sodium channel, voltage-gated, type I, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type IV, beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel associated protein 1 MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel associated protein 2 MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type III, beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type I, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type IX, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type VII, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
amiloride-sensitive cation channel 5, intestinal MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type III, beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type XI, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type I, beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type 10, alpha polypeptide MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type IV, alpha polypeptide MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type V, alpha polypeptide MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type II, beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, nonvoltage-gated 1 alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, nonvoltage-gated 1 gamma MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, nonvoltage-gated 1 beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type XI, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, nonvoltage-gated 1, gamma MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, nonvoltage-gated 1, delta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, nonvoltage-gated 1 alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type X, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type IX, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage gated, type VIII, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type VII, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type IV, beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type IV, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type III, alpha MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type II, beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type II, alpha 2 MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
sodium channel, voltage-gated, type I, beta MESTRANOL Sodium Channel, Site 2 93% 5.601uM 5.021uM View
adrenergic receptor, alpha 2c (Non-specific probe) ERGOTAMINE Imidazoline I2, Central 93% .003645uM .00243uM View
calcium channel, voltage-dependent, beta 2 subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, alpha 1F subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, beta 1 subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, gamma subunit 8 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, gamma subunit 7 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, gamma subunit 6 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, gamma subunit 5 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, gamma subunit 4 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, gamma subunit 3 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, gamma subunit 2 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, gamma subunit 1 TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, beta 4 subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
calcium channel, voltage-dependent, beta 3 subunit TERCONAZOLE Calcium Channel Type L, Benzothiazepine 93% 3.008uM 2.674uM View
cholinergic receptor, muscarinic 1 PROCHLORPERAZINE Muscarinic M1 93% 1.013uM .244uM View
dopamine receptor D3 METOCLOPRAMIDE Dopamine D3 93% .2uM .068uM View
opioid receptor, sigma 1 PIPAMAZINE Sigma1 93% .114uM .048uM View
dopamine receptor 2 CYPROHEPTADINE Dopamine D2L 93% .164uM .055uM View
A3 adenosine receptor DISULFIRAM Adenosine A3 93% .356uM .201uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit EBASTINE Calcium Channel Type L, Dihydropyridine 92% .1436uM .0923uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit EBASTINE Calcium Channel Type L, Dihydropyridine 92% .1436uM .0923uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 EBASTINE Calcium Channel Type L, Dihydropyridine 92% .1436uM .0923uM View
adrenergic receptor, alpha 1a PROMETHAZINE Adrenergic alpha1A 92% .079uM .032uM View
5-hydroxytryptamine (serotonin) receptor 2A CETYLPYRIDINIUM BROMIDE Serotonin 5-HT2A 92% 3.173uM .907uM View
adrenergic receptor, alpha 2a RALOXIFENE Adrenergic alpha2A 92% 1.664uM .624uM View
dopamine receptor 2 RALOXIFENE Dopamine D2L 92% 1.174uM .391uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 4-NONYLPHENOL Adrenergic, Norepinephrine Transporter 92% 1.254uM 1.244uM View
opioid receptor, kappa 1 ASTEMIZOLE Opiate kappa 92% 6.616uM 2.646uM View
5-hydroxytryptamine (serotonin) receptor 2A CLOMIPHENE Serotonin 5-HT2A 92% 3.308uM .945uM View
5-hydroxytryptamine (serotonin) receptor 2C CLOMIPHENE Serotonin 5-HT2C 92% 1.272uM .666uM View
adrenergic receptor, beta 3 PROPAFENONE Adrenergic beta3 92% .424uM .318uM View
androgen receptor TIBOLONE Testosterone 92% .113uM .0754uM View
5-hydroxytryptamine (serotonin) receptor 2B S-(-)-PROPRANOLOL Serotonin 5-HT2B 92% .411uM .262uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ITRACONAZOLE Sodium Channel, Site 2 92% 2.577uM 2.351uM View
sodium channel, voltage-gated, type IV, beta ITRACONAZOLE Sodium Channel, Site 2 92% 2.577uM 2.351uM View
sodium channel, voltage-gated, type IV, alpha ITRACONAZOLE Sodium Channel, Site 2 92% 2.577uM 2.351uM View
sodium channel, voltage-gated, type III, alpha ITRACONAZOLE Sodium Channel, Site 2 92% 2.577uM 2.351uM View